Share:
Peer-Reviewed Publication
Postgrad Med2025;137(7):601-608.September 1, 2025Journal Article

Feasibility of a virtual, prospective real-world data study in acute rhinosinusitis.

Claudia B Bittner1, Michael Plach1, Stefan Hoch1, Hubert Steindl1, Lisa Klein2,3, Tobias Kruse2,3, Christoph Abels1, Claus Bachert4
1Research & Development, Bionorica SE, Neumarkt i.d.OPf., Germany.
2Trials24 GmbH, Munich, Germany.
3Part of SubjectWell, Austin, TX, USA.
4Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital of Münster, Münster, Germany.

Abstract

OBJECTIVES: This exploratory study evaluated the feasibility of solely virtually recruiting patients with symptoms suggestive of acute rhinosinusitis (ARS) and whether a questionnaire-based study on disease history, use of over-the-counter (OTC) medications and symptom burden in ARS can provide plausible and meaningful results. METHODS: The study was advertised via Google Ads and on social media…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.